DarioHealth Financial Statements From 2010 to 2026

DRIO Stock  USD 11.28  0.15  1.31%   
DarioHealth Corp's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing DarioHealth Corp's valuation are provided below:
Gross Profit
16.8 M
Profit Margin
(1.71)
Market Capitalization
76.2 M
Enterprise Value Revenue
3.1918
Revenue
24.7 M
We have found one hundred twenty available fundamental signals for DarioHealth Corp, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to verify DarioHealth Corp's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 21st of February 2026, Market Cap is likely to drop to about 738.9 M. In addition to that, Enterprise Value is likely to drop to about 732.5 M

DarioHealth Corp Total Revenue

32.65 Million

Check DarioHealth Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DarioHealth Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9 M, Interest Expense of 82.1 K or Selling General Administrative of 24.7 M, as well as many indicators such as Price To Sales Ratio of 42.67, Dividend Yield of 0.0 or PTB Ratio of 14.02. DarioHealth financial statements analysis is a perfect complement when working with DarioHealth Corp Valuation or Volatility modules.
  
Build AI portfolio with DarioHealth Stock
Check out the analysis of DarioHealth Corp Correlation against competitors.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.

DarioHealth Corp Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets143.6 M136.7 M48.2 M
Slightly volatile
Other Current Liabilities7.3 MM3.2 M
Slightly volatile
Total Current Liabilities20.1 M19.1 M7.8 M
Slightly volatile
Property Plant And Equipment Net1.3 MM1.2 M
Slightly volatile
Accounts Payable2.1 M3.5 M1.8 M
Slightly volatile
Cash18.8 M31.9 M16.2 M
Slightly volatile
Non Current Assets Total94.6 M90.1 M25.4 M
Slightly volatile
Non Currrent Assets Other473.3 K450.8 K141.5 K
Slightly volatile
Cash And Short Term Investments19 M32.7 M16.4 M
Slightly volatile
Net Receivables6.5 M6.2 MM
Slightly volatile
Common Stock Total Equity4.5 K3.5 K3.4 K
Pretty Stable
Common Stock Shares Outstanding81.1 M77.3 M17.9 M
Slightly volatile
Short Term Investments841.6 K801.5 K291.6 K
Slightly volatile
Liabilities And Stockholders Equity143.6 M136.7 M48.2 M
Slightly volatile
Other Current Assets2.4 M2.3 M1.1 M
Slightly volatile
Other Stockholder Equity558.3 M531.7 M191.9 M
Slightly volatile
Total Liabilities56.6 M53.9 M18 M
Slightly volatile
Property Plant And Equipment Gross4.4 M4.2 M1.8 M
Slightly volatile
Total Current Assets24.5 M46.6 M21.4 M
Slightly volatile
Common Stock4.3 K4.6 K3.5 K
Slightly volatile
Other Liabilities778 K819 K1.9 M
Slightly volatile
Capital Surpluse441.8 M420.7 M173 M
Slightly volatile
Property Plant Equipment708.3 K709.2 K898.9 K
Slightly volatile
Short and Long Term Debt Total36.5 M34.7 M10.5 M
Slightly volatile
WarrantsM2.1 M2.4 M
Slightly volatile
Current Deferred RevenueM1.8 M749.4 K
Slightly volatile
Inventory3.2 M5.5 M2.4 M
Slightly volatile
Deferred Long Term Liabilities778 K819 K2.2 M
Slightly volatile
Preferred Stock Total EquityM2.1 M2.4 M
Slightly volatile
Long Term Debt18.8 M27 M13.8 M
Slightly volatile
Long Term Debt Total11.3 M20.8 M12.3 M
Slightly volatile
Net Invested Capital60.5 M116.1 M37.9 M
Slightly volatile
Net Working Capital26.4 M27.5 M15.7 M
Slightly volatile
Capital Lease Obligations912.3 K1.5 M840.9 K
Slightly volatile
Short Term Debt3.7 M6.8 MM
Slightly volatile
Non Current Liabilities Other21.4 K22.5 K652 K
Slightly volatile
Intangible Assets12.8 M21.6 M12.8 M
Pretty Stable
Short and Long Term Debt4.9 M4.9 M7.9 M
Slightly volatile

DarioHealth Corp Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And AmortizationM8.5 M2.5 M
Slightly volatile
Selling General Administrative24.7 M23.6 M10.4 M
Slightly volatile
Selling And Marketing Expenses31.8 M30.3 M13.9 M
Slightly volatile
Other Operating Expenses102.4 M97.5 M41.7 M
Slightly volatile
Research Development29.2 M27.8 M10.1 M
Slightly volatile
Total Operating Expenses85.7 M81.7 M34.8 M
Slightly volatile
Cost Of Revenue9.1 M15.8 M9.7 M
Pretty Stable
Preferred Stock And Other Adjustments226.6 K238.5 KM
Slightly volatile
Interest Income1.3 M1.3 M658.3 K
Slightly volatile
Reconciled DepreciationM8.5 M2.4 M
Slightly volatile

DarioHealth Corp Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation9.1 M18.2 M8.1 M
Slightly volatile
Begin Period Cash Flow44.4 M42.3 M16.7 M
Slightly volatile
DepreciationM8.5 M2.5 M
Slightly volatile
Capital Expenditures118 K124.2 K398 K
Slightly volatile
Total Cash From Financing Activities26 M44.3 M22.7 M
Slightly volatile
End Period Cash Flow18.8 M31.9 M16.2 M
Slightly volatile
Change To Netincome20.5 M19.5 M8.3 M
Slightly volatile
Issuance Of Capital Stock36.1 M44.3 M27.1 M
Slightly volatile
Dividends Paid19 M21.4 M23.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio42.6744.92269
Slightly volatile
Days Sales Outstanding69.6583.08106
Slightly volatile
Stock Based Compensation To Revenue0.640.6710.356
Slightly volatile
Capex To Depreciation0.02030.02144.2886
Slightly volatile
EV To Sales42.7745.02276
Slightly volatile
Inventory Turnover3.943.335.0295
Slightly volatile
Days Of Inventory On Hand97.011399.6695
Slightly volatile
Payables Turnover6.115.28.6702
Slightly volatile
Sales General And Administrative To Revenue0.830.8721.8092
Slightly volatile
Research And Ddevelopement To Revenue0.981.0323.4183
Slightly volatile
Capex To Revenue0.00560.00593.2807
Slightly volatile
Cash Per Share0.460.4941.9025
Slightly volatile
Days Payables Outstanding13692.8104
Pretty Stable
Income Quality0.550.810.673
Slightly volatile
Intangibles To Total Assets0.420.580.5296
Pretty Stable
Current Ratio2.232.192.7416
Pretty Stable
Receivables Turnover5.525.818.889
Very volatile
Capex Per Share0.00220.002418.2629
Slightly volatile
Revenue Per Share0.440.463.3008
Slightly volatile
Interest Debt Per Share0.490.5235.3893
Slightly volatile
Debt To Assets0.310.290.381
Slightly volatile
Operating Cycle148178203
Slightly volatile
Days Of Payables Outstanding13692.8104
Pretty Stable
Ebt Per Ebit1.140.891.0825
Slightly volatile
Long Term Debt To Capitalization0.190.220.1972
Slightly volatile
Total Debt To Capitalization0.320.343.8487
Slightly volatile
Quick Ratio2.021.942.5031
Very volatile
Net Income Per E B T1.091.11.0091
Slightly volatile
Cash Ratio1.71.52.0651
Pretty Stable
Days Of Inventory Outstanding97.011399.6695
Slightly volatile
Days Of Sales Outstanding69.6583.08106
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.161.151.0758
Slightly volatile
Fixed Asset Turnover14.413.727.1642
Slightly volatile
Debt Ratio0.310.290.381
Slightly volatile
Price Sales Ratio42.6744.92269
Slightly volatile
Asset Turnover0.350.260.2496
Slightly volatile

DarioHealth Corp Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap738.9 M950.5 M1.2 B
Slightly volatile
Enterprise Value732.5 M952.7 M1.2 B
Slightly volatile

DarioHealth Fundamental Market Drivers

Forward Price Earnings10.5932
Cash And Short Term Investments28.5 M

DarioHealth Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About DarioHealth Corp Financial Statements

DarioHealth Corp investors utilize fundamental indicators, such as revenue or net income, to predict how DarioHealth Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.8 MM
Total Revenue31.1 M32.7 M
Cost Of Revenue15.8 M9.1 M
Stock Based Compensation To Revenue 0.67  0.64 
Sales General And Administrative To Revenue 0.87  0.83 
Research And Ddevelopement To Revenue 1.03  0.98 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.46  0.44 
Ebit Per Revenue(1.92)(2.02)

Pair Trading with DarioHealth Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.

Moving against DarioHealth Stock

  0.62ALMDT MediantechnPairCorr
  0.32FDBK Feedback PLC Earnings Call This WeekPairCorr
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DarioHealth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DarioHealth Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dariohealth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dariohealth Corp Stock:
Check out the analysis of DarioHealth Corp Correlation against competitors.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Will Health Care Technology sector continue expanding? Could DarioHealth diversify its offerings? Factors like these will boost the valuation of DarioHealth Corp. Projected growth potential of DarioHealth fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DarioHealth Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(10.87)
Revenue Per Share
8.268
Quarterly Revenue Growth
(0.33)
Return On Assets
(0.21)
Return On Equity
(0.63)
DarioHealth Corp's market price often diverges from its book value, the accounting figure shown on DarioHealth's balance sheet. Smart investors calculate DarioHealth Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since DarioHealth Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between DarioHealth Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DarioHealth Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.